Antisense inhibition of E2F transcription factor 3 expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 26, 2000
Grant Date -
N/A
app pub date -
Feb 24, 2000
filing date -
Feb 24, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of E2F transcription factor 3. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding E2F transcription factor 3. Methods of using these compounds for modulation of E2F transcription factor 3 expression and for treatment of diseases associated with expression of E2F transcription factor 3 are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully